Invitation to Science & Network
The pathogenesis behind and treatment of pancreatic cancer
Time: Monday, September 30, 2024
Place: Rigshospitalet, Auditorium 93, Juliane Maries vej 20, Opgang 93
Moderator: Inna Chen
Program:
16:00 – 16:10: Welcome Inna Chen
16:10 – 16:30: The patient with pancreatic cancer: Pathogenesis and oncological treatment Inna Chen, Consultant.Herlev Hospital, Department of Oncology.
16:30 – 16:50: The surgical treatment of pancreatic cancer Stefan Kobbelgaard Burgdorf, Consultant, PhD, Associate Professor. Rigshospitalet, Department of Surgery.
16:50 – 17:10 The pathological characteristics of pancreatic cancer Deepthi Chiranth, Consultant, Rigshospitalet, Department of Pathology
17.10 – 17.30 Break – Network and Sandwich
17:30 – 17:50 Biomarkers in treatment of pancreatic cancer: Sidsel Christy Lindgaard, PhD, post doc. Herlev Hospital, Department of Oncology
Experimental treatment of pancreatic cancer
17:50 – 18:10: Dual-mechanistic uPAR-directed Antibody-Drug conjugates for treating pancreatic cancer Virginia Metrangolo Post doc. Engelholm group, The Finsen Laboratory/BRIC
18:10 – 18:30: Preoperative priming of the patient with pancreatic cancer: the IMPULS trial Adile Orhan, MD, PhD student, Center for Surgical Science, Zealand University Hospital
18:30 – 18:40: Rounding up and questions
All are welcome, but please register your participation not later than 23. September 2024.
The meeting will be held in English.
